Light emitting diode (LED) device manufacturer BioPhotas has introduced the Celluma iSeries to the Celluma portfolio of light therapy devices. The series offers battery-powered options of the company’s most popular models, the Celluma PRO and the Celluma LITE.
BioPhotas will also be offering to upgrade any previously sold Celluma devices with the battery powered option, allowing current owners to get the latest technology features.
Commenting on these developments, president and CEO of BioPhotas, Patrick Johnson said, “We are excited to introduce the Celluma iSeries, the first battery-powered LED ‘panel’ device that is FDA-cleared and medical CE-marked for treating a variety of skin, muscle and joint conditions. Now the convenience and efficacy of the Celluma series is enhanced so it can be used anywhere and anytime. Advances in battery technology have also allowed us to provide multiple Celluma treatment cycles without impeding versatility or portability.”